BOLT Bolt Biotherapeutics, Inc.
Bolt Biotherapeutics, Inc. (BOLT) Institutional Ownership
What the institutions did with BOLT last quarter, from their 13F filings. Counting managers rather than shares is the point: a single index fund adding to a position tells you far less than four hundred separate managers all deciding to. Positions as reported for the quarter ended June 30, 2026.
Every manager below opens. Subscribers can see any firm's whole portfolio — every position, its weight, and what they bought, trimmed and exited last quarter.
Sign in or subscribeLargest holders
| Manager | Shares | % of reported |
|---|---|---|
| Sofinnova Investments, Inc. | 137.7K | 23.1% |
| RENAISSANCE TECHNOLOGIES LLC | 98.6K | 16.5% |
| Vivo Capital, LLC | 72.4K | 12.1% |
| CITADEL ADVISORS LLC | 56.9K | 9.5% |
| T3 Companies, LLC | 38.0K | 6.4% |
| Board of Trustees of The Leland Stanford Junior University | 36.0K | 6.0% |
| Pfizer Inc | 31.3K | 5.2% |
| Lynx1 Capital Management LP | 30.8K | 5.2% |
| NANO CAP NEW MILLENNIUM GROWTH FUND L P | 27.5K | 4.6% |
| GEODE CAPITAL MANAGEMENT, LLC | 19.1K | 3.2% |
| Shay Capital LLC | 15.4K | 2.6% |
| BlackRock, Inc. | 9.7K | 1.6% |
| VANGUARD CAPITAL MANAGEMENT LLC | 7.1K | 1.2% |
| Nan Fung Group Holdings Ltd | 5.0K | 0.8% |
| MORGAN STANLEY | 3.1K | 0.5% |
| VANGUARD FIDUCIARY TRUST CO | 3.1K | 0.5% |
| NewEdge Advisors, LLC | 2.5K | 0.4% |
| Tower Research Capital LLC (TRC) | 1.7K | 0.3% |
| UBS Group AG | 255 | 0.0% |
| SBI Securities Co., Ltd. | 130 | 0.0% |
| JPMORGAN CHASE & CO | 42 | 0.0% |
| CITIGROUP INC | 41 | 0.0% |
| BARCLAYS PLC | 6 | 0.0% |
Largest changes
| Manager | Action | Previous | Current | Change |
|---|---|---|---|---|
| CITADEL ADVISORS LLC | Increased | 10.1K | 56.9K | +46.8K |
| Pivotal bioVenture Partners Investment Advisor LLC | Sold Out | 42.6K | 0 | -42.6K |
| Nan Fung Group Holdings Ltd | Reduced | 29.3K | 5.0K | -24.3K |
| RENAISSANCE TECHNOLOGIES LLC | Increased | 77.2K | 98.6K | +21.4K |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | Sold Out | 11.7K | 0 | -11.7K |
| GEODE CAPITAL MANAGEMENT, LLC | Reduced | 28.8K | 19.1K | -9.7K |
| NewEdge Advisors, LLC | New | 0 | 2.5K | +2.5K |
| Tower Research Capital LLC (TRC) | Increased | 1.1K | 1.7K | +617 |
| Shay Capital LLC | Increased | 14.9K | 15.4K | +533 |
| UBS Group AG | Reduced | 787 | 255 | -532 |
| SBI Securities Co., Ltd. | Increased | 10 | 130 | +120 |
| MORGAN STANLEY | Reduced | 3.2K | 3.1K | -44 |
| CITIGROUP INC | New | 0 | 41 | +41 |
| Vanguard Global Advisers, LLC | Sold Out | 24 | 0 | -24 |
13F filings are due 45 days after quarter end and cover long positions in U.S.-listed equities only, so this is a lagged and partial picture: shorts, bonds and foreign listings never appear. Options positions are excluded here rather than folded into the share counts. Political ownership is coming.